InvestorsHub on MSN
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare
BioLabs, Inc. (NASDAQ:AIDX) announced it has signed an exclusive U.S. technology licensing and access agreement with ROKIT ...
Shares of 20/20 Biolabs, Inc. AIDX are trading lower Tuesday after the company announced that it entered into an exclusive U.S. technology license and access agreement with ROKIT Healthcare. 20/20 ...
This is Part 6 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it's so difficult to change them. NEW YORK — One Brooklyn Health, a safety net hospital ...
Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk Inc. to stratify risk and assess the progressive decline in kidney ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Several years ago, nephrologists attempted a first-of-its-kind effort ...
Source: Getty Images A clinician pondered the downstream consequences of trusting a statistical AI model over longitudinal clinical experience and judgment. Artificial intelligence (AI) is rapidly ...
Algorithms are designed to make medicine more accurate. But when race is factored in, they can worsen inequality. NOVA is available to stream on pbs.org and the free PBS App, available on iPhone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results